Cochrane Abstracts
Vascular endothelial growth factor (VEGF) inhibitors for the treatment of metastatic and recurrent cervical cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Metastatic and Recurrent Cervical Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431950/all/Vascular_endothelial_growth_factor__VEGF__inhibitors_for_the_treatment_of_metastatic_and_recurrent_cervical_cancer.
Vascular endothelial growth factor (VEGF) inhibitors for the treatment of metastatic and recurrent cervical cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431950/all/Vascular_endothelial_growth_factor__VEGF__inhibitors_for_the_treatment_of_metastatic_and_recurrent_cervical_cancer. Accessed January 15, 2025.
Vascular endothelial growth factor (VEGF) inhibitors for the treatment of metastatic and recurrent cervical cancer. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431950/all/Vascular_endothelial_growth_factor__VEGF__inhibitors_for_the_treatment_of_metastatic_and_recurrent_cervical_cancer
Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Metastatic and Recurrent Cervical Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431950/all/Vascular_endothelial_growth_factor__VEGF__inhibitors_for_the_treatment_of_metastatic_and_recurrent_cervical_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Vascular endothelial growth factor (VEGF) inhibitors for the treatment of metastatic and recurrent cervical cancer
ID - 431950
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431950/all/Vascular_endothelial_growth_factor__VEGF__inhibitors_for_the_treatment_of_metastatic_and_recurrent_cervical_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
